Cargando…
Gandi Capsule Improved Podocyte Lipid Metabolism of Diabetic Nephropathy Mice through SIRT1/AMPK/HNF4A Pathway
Podocyte lipid accumulation is a potential therapeutic target for diabetic nephropathy (DN). This study was aimed at clarifying the mechanism of Gandi capsule (GDC) ameliorating DN by regulating the lipid metabolism of podocytes. Network pharmacology methods were performed to screen the key molecule...
Autores principales: | Zhang, Ying, Yao, Huijuan, Li, Chao, Sun, Wei, Chen, Xiaofei, Cao, Yan, Liu, Yue, Liu, Yan, Chen, Jihui, Qi, Jia, Zhang, Qiqiang, Zhang, Hai, Xu, Ajing, Zhang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038418/ https://www.ncbi.nlm.nih.gov/pubmed/35480869 http://dx.doi.org/10.1155/2022/6275505 |
Ejemplares similares
-
Revealing active components, action targets and molecular mechanism of Gandi capsule for treating diabetic nephropathy based on network pharmacology strategy
por: Zhang, Qiqiang, et al.
Publicado: (2020) -
Revealing Synergistic Mechanism of Multiple Components in Gandi Capsule for Diabetic Nephropathy Therapeutics by Network Pharmacology
por: Zhang, Jian, et al.
Publicado: (2018) -
Correction: Comparative pharmacokinetics of four active components on normal and diabetic rats after oral administration of Gandi capsules
por: Xu, Renjie, et al.
Publicado: (2018) -
Comparative pharmacokinetics of four active components on normal and diabetic rats after oral administration of Gandi capsules
por: Xu, Renjie, et al.
Publicado: (2018) -
Yishen capsule promotes podocyte autophagy through regulating SIRT1/NF-κB signaling pathway to improve diabetic nephropathy
por: Liu, Yuxiang, et al.
Publicado: (2021)